-65.7%
MRNA vs ARMK
+160.7%
-226.4%
-95.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | ARMK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +3.2% | +2.2% | +4.4% |
| 7D | -1.1% | +3.1% | -4.2% | -2.0% |
| 30D | +126.1% | -2.8% | +128.9% | +127.7% |
| 3M | +190.0% | +7.6% | +182.4% | +181.4% |
| 6M | +157.2% | +47.9% | +109.3% | +121.5% |
| YTD | +388.2% | +60.0% | +328.2% | +308.3% |
| 1Y | +467.0% | +52.2% | +414.8% | +382.5% |
| 3Y | +36.1% | +131.4% | -95.3% | -1.8% |
| All | -65.7% | +160.7% | -226.4% | -75.6% |
Cumulative growth
Daily Returns
Daily percentage return beside ARMK.
Daily Out/Under-Performance
Portfolio return minus ARMK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ARMK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded ARMK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling